Defective DNA topoisomerase II in ataxia-telangiectasia cells.
A number of characteristics in the human genetic disorder ataxia-telangiectasia are compatible with an alteration to chromatin structure or the recognition of that structure by an enzyme or DNA binding protein. We describe here reduce activity of DNA topoisomerase type II in a number of Epstein Barr Virus-transformed ataxia-telangiectasia lymphoblastoid cell lines. Enzyme activity was reduced 10-fold or greater in 4 out of 5 cell lines compared to controls. In the remaining cell line approximately a 2-3 fold reduction was evident in partially purified extracts. DNA topoisomerase type I activity was found to be the same as controls in all the cell lines. Northern blot analysis revealed that the same level of DNA topoisomerase II mRNA was expressed in ataxia-telangiectasia and control cell lines. The size and amount of the enzyme did not differ appreciably from that observed in control cells. The reduced activity of DNA topoisomerase II in ataxia-telangiectasis cells might be explained by amino acid substitutions, small deletions in DNA or by a defect in post-translational modification in these cells.
Lavin
M F
MF
Department of Biochemistry, University of Queensland, Brisbane, Australia.
Singh
S P
SP
D001260:Ataxia Telangiectasia / Q000201:enzymology* / Q000235:genetics; D002460:Cell Line; D004261:DNA Replication / Q000235:genetics; D004250:DNA Topoisomerases, Type II / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D009154:Mutation; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism
D012333:RNA, Messenger; D004250:DNA Topoisomerases, Type II